Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease

Transplantation Proceedings

Volumn 42, Issue 9, 2010, Pages 3444-3449

  Mesquita, M ^a   Demulder, A ^a   Wolff, F ^a   Melot C ^b   Damry, N ^a   Dratwa, M ^a   Bergmann, P ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; AORTA; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL;

ADULT; AGED; AORTIC DISEASES; BELGIUM; BIOLOGICAL MARKERS; CALCINOSIS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LEAST-SQUARES ANALYSIS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PROGNOSIS; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649475470     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.129     Document Type: Article

References (30)

1. G.M. London Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function J Am Soc Nephrol 14 2003 S305
2. R.N. Folley, P.S. Parfrey, and M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 1998 112
3. D. Hernandez, M. Rufino, and S. Bartolomei Clinical impact of preexisting vascular calcifications on mortality after renal transplantation Kidney Int 67 2005 2015
4. K.A. Hiruska, S. Mathew, and R. Lund Hyperphosphatemia of chronic kidney disease Kidney Int 74 2008 148
5. P. Raggi, A. Boulay, and S. Chasan-Taber Cardiac calcification in adult hemodialysis patients A link between end stage renal disease and cardiovascular disease? J Am Coll Cardiol 39 2002 695
6. W.G. Goodman, J. Goldin, and B.D. Kuizon Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 18 2000 1478
7. S.M. Moe, and N.X. Chen Inflammation and vascular calcification Blood Purif 23 2005 64
8. G. Cianciolo, G. La Manna, and G. Donati Coronary calcifications in end-stage renal disease patients: a new link between osteoprotegerin, diabetis and body mass index? Blood Purif 29 2010 13
9. C.M. Giachelli Vascular calcification mechanisms J Am Soc Nephrol 15 2004 2959
10. A.P. Gurin, G.M. London, and S.J. Marchais Arterial stiffening and vascular calcifications in end stage renal disease Nephrol Dial Transplant 15 2000 1014
11. J. Takasu, M.J. Budoff, and K.D. O'Brien Relationship between coronary artery and descending thoracic aortic calcification as detected by computed tomography: The Multi-Ethnic Study of Atherosclerosis Atherosclerosis 204 2009 440
12. S.M. Moe, K.D. O'Neil, and N. Fineberg Assessment of vascular calcification in ESRD patients using spiral CT Nephrol Dial Transplant 18 2003 1152
13. K. Nitta, T. Akiba, and K. Suzuki Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan Hypertens Res 27 2004 527
14. P. Reid, and I. Holen Pathophysiological roles of osteoprotegerin (OPG) Eur J Cell Biol 88 2009 1
15. A. Van Campenhout, and J. Golledge Osteoprotegerin, vascular calcification and atherosclerosis Atherosclerosis 204 2009 321
16. N. Bucay, I. Sarosi, and C.R. Dunstan Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification Genes Dev 12 1998 1260
17. S.M. Moe, K.D. O'Neil, and M. Resterova Natural history of vascular calcification in dialysis and transplant patients Nephrol Dial Transplant 19 2004 2387
18. M. Mesquita, A. Demulder, and N. Damry Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease Clin Chem Lab Med 47 2009 339
19. L. Amal, and P. Bergmann Evaluation of a chemiluminescence immunoassay for the determination of intact parathyroid hormone using the ADVIA Centaur® Clin Lab 50 2004 695
20. D.G. Jones, A.M. Taylor, and S.A. Enkiri Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation Am J Transplant 9 2009 1846
21. S.K. Ganesh, A.G. Stack, and N.W. Levin Association of elevated serum PO (4), Ca × PO (4) product and parathyroid hormone with mortality risk in chronic hemodialysis patients J Am Soc Nephrol 12 2001 2113
22. J. Blacher, A.P. Guerin, and B. Pannier Arterial calcifications, arterial stiffness and cardiovascular risk in end-stage renal disease Hypertension 38 2001 938
23. T. Ogawa, H. Ishida, and N. Matsuda Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients Hemodial Int 13 2009 301
24. A.S. Agatston, W.R. Janowitz, and F.J. Hildner Quantification of coronary artery calcifications using ultrafast computed tomography J Am Coll Cardiol 15 1990 827
25. S.S. DeLoach, M.M. Joffe, and X. Mai Aortic calcification predicts cardiovascular events and all-cause mortality in renal transplantation Nephrol Dial Transplant 24 2009 1314
26. B.R. Kestenbaum, K.L. Adeney, and I.H. de Broer Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis Kidney Int 76 2009 991
27. A.S. Bargnoux, A.M. Dupuy, and V. Garrigue Renal transplantation decreases osteoprotegerin levels Transplant Proc 38 2006 2317
28. J. Hjelmesæth, T. Ueland, and A. Flyvbjerg Early post transplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients J Am Soc Nephrol 17 2006 1746
29. T. Sato, Y. Tominaga, and Y. Iwasaki Osteoprotegerin levels before and after renal transplantation Am J Kidney Dis 38 2001 S175
30. A. Fahrleiter, G. Prenner, and G. Leb Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation Bone 32 2003 96.